These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19102503)

  • 1. [Expressions of MMP-2 and COX-2 mRNA in bladder transitional cell carcinoma and their correlation].
    Zhang HP; Yu B; Zheng XD; Hu HJ; Gao ZB; Li L; Zhou LF
    Zhonghua Nan Ke Xue; 2008 Nov; 14(11):1011-4. PubMed ID: 19102503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of the expression of cyclooxygenase-2 in bladder transitional cell carcinoma tissues].
    Ren L; Hou SK; He LF; Ye HY; Guan KP
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1104-7. PubMed ID: 15498296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
    Zhan J; Tang XD
    Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of cyclooxygenase in bladder transitional cell carcinoma].
    Wang KJ; Li H; Wei Q; Yang YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof].
    Yu L; Chen XJ; Shi PQ; Ding Q; Sun CH; Liu GB; Shi DM; Huang YG
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2683-4. PubMed ID: 19080686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma.
    Xu K; Hou S; Du Z
    Chin Med J (Engl); 2002 May; 115(5):743-5. PubMed ID: 12133547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mRNA expression of platelet-derived endothelial cell growth factor of bladder transitional cell carcinoma and its relation to invasiveness].
    Li G; Zhang YF; Ding Q; Wen DG; Yan CY
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):30-2. PubMed ID: 15059350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis].
    Wu SH; Zhang J; Li Y; Li JM
    Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.
    Byun JH; Lee MA; Roh SY; Shim BY; Hong SH; Ko YH; Ko SJ; Woo IS; Kang JH; Hong YS; Lee KS; Lee AW; Park GS; Lee KY
    Jpn J Clin Oncol; 2006 May; 36(5):263-8. PubMed ID: 16735371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of uPA and uPAR expression with invasive behaviors of urinary transitional cell carcinoma].
    Li YJ; Zheng BZ; Zhou ZL
    Ai Zheng; 2004 Jun; 23(6):704-6. PubMed ID: 15191676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].
    Tang ZY; Yang LY; Zhang YJ; Peng KL; Qi L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):363-6. PubMed ID: 16859125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinoma.
    Seargent JM; Loadman PM; Martin SW; Naylor B; Bibby MC; Gill JH
    Urology; 2005 Apr; 65(4):815-20. PubMed ID: 15833553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
    Sumi T; Yoshida H; Hyun Y; Yasui T; Matsumoto Y; Hattori K; Sugimura K; Kawashima H; Nakatani T; Ishiko O
    Oncol Rep; 2003; 10(2):345-9. PubMed ID: 12579270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
    Davies B; Waxman J; Wasan H; Abel P; Williams G; Krausz T; Neal D; Thomas D; Hanby A; Balkwill F
    Cancer Res; 1993 Nov; 53(22):5365-9. PubMed ID: 8221672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of clusterin expression to prognosis of bladder carcinoma].
    Luo JH; Xie D; Chen W; Dai YP; Li XF; Tao Y; Zheng KL
    Ai Zheng; 2005 Jun; 24(6):743-7. PubMed ID: 15946493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.
    Choi YD; Cho NH; Ahn HS; Cho KS; Cho SY; Yang WJ
    J Urol; 2007 Mar; 177(3):1174-8. PubMed ID: 17296440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REG1A predicts recurrence in stage Ta/T1 bladder cancer.
    Geng J; Fan J; Wang P; Fang ZJ; Xia GW; Jiang HW; Chen G; Ding Q
    Eur J Surg Oncol; 2009 Aug; 35(8):852-7. PubMed ID: 19167858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of platelet-derived endothelial cell growth factor mRNA expression in superficial bladder cancer].
    Li G; Zhang YF; Ding Q; Yan CY; Wen DG
    Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(8):478-81. PubMed ID: 15144643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.